Samarth Kulkarni - Chief Executive Officer, Crispr Therapeutics Ag

As of March 14, 2022


Samarth Kulkarni Net Worth

  • Net worth is estimated to be at least $30.74M
  • Owns at least 187,719 units of Crispr Therapeutics Ag stock
  • Sold an estimated value of $25.46M in the last 5 years at Crispr Therapeutics Ag

Samarth Kulkarni Trading

  • Largest purchase of shares was 30,000 units , worth over $377.1K on August 6, 2021
  • Largest sale of shares was 20,000 units , worth over $4.27M on January 20, 2021
  • In total has made about 46 transactions over 5 years
  • Usually trades in December, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Samarth Kulkarni Mailing Address

  • Mailing address is C/o Crispr Therapeutics Ag 200 Sidney Street Cambridge MA 02139 MA

Crispr Therapeutics Ag Insider Trading

  • The most recent transaction was 25,000 units sold on August 10, 2021 by John Michael Tomsicek worth over $3.46M
  • In the last 5 years, insiders at Crispr Therapeutics Ag sold an estimated value of $383.13M and bought an estimated value of $55.06M
  • The most active traders are Samarth Kulkarni, Chief Executive Officer,  Bradley Bolzon, Director,  and Rodger Novak, President
  • Insider trading is most common in June, with the busiest year in 2017

CRISPR Therapeutics AG Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1